Daniel Antonio Perez Sells 166,665 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) CEO Daniel Antonio Perez sold 166,665 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $40.26, for a total transaction of $6,709,932.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Daniel Antonio Perez also recently made the following trade(s):

• On Monday, January 5th, Daniel Antonio Perez sold 166,665 shares of Hinge Health stock. The stock was sold at an average price of $46.38, for a total value of $7,729,922.70.
• On Monday, December 15th, Daniel Antonio Perez sold 166,670 shares of Hinge Health stock. The shares were sold at an average price of $48.53, for a total value of $8,088,495.10.

Hinge Health Price Performance

Shares of HNGE opened at $38.91 on Friday. The firm has a market cap of $3.06 billion and a P/E ratio of -2.97. The stock has a 50 day simple moving average of $43.53 and a two-hundred day simple moving average of $48.79. Hinge Health Inc. has a 1 year low of $30.08 and a 1 year high of $62.18.

Hinge Health announced that its Board of Directors has authorized a share buyback program on Wednesday, November 12th that allows the company to repurchase $250.00 million in shares. This repurchase authorization allows the company to purchase up to 7.2% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

Institutional Investors Weigh In On Hinge Health

Institutional investors and hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN increased its stake in shares of Hinge Health by 160.0% during the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after buying an additional 336 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in Hinge Health during the 3rd quarter valued at $37,000. First Horizon Corp increased its position in Hinge Health by 163.9% during the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after purchasing an additional 531 shares during the period. Montag A & Associates Inc. bought a new position in Hinge Health in the 2nd quarter worth $41,000. Finally, High Point Wealth Management LLC bought a new stake in shares of Hinge Health during the 4th quarter valued at about $46,000.

Analyst Ratings Changes

Several research firms have weighed in on HNGE. Wall Street Zen downgraded shares of Hinge Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 28th. Freedom Capital raised Hinge Health to a “strong-buy” rating in a research note on Thursday, January 22nd. Barclays dropped their target price on Hinge Health from $60.00 to $52.00 and set an “overweight” rating for the company in a report on Wednesday. Piper Sandler decreased their price target on Hinge Health from $71.00 to $60.00 and set an “overweight” rating on the stock in a research note on Friday, January 9th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Hinge Health in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Hinge Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $57.71.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.